Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


From public health genomics to precision public health: a 20-year journey.

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, Kolor K, Rodriguez JL, Wulf A, Yu W.

Genet Med. 2017 Dec 14. doi: 10.1038/gim.2017.211. [Epub ahead of print] Review.


Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.

Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.

Genet Med. 2017 Sep 21. doi: 10.1038/gim.2017.118. [Epub ahead of print]


BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.


A knowledge base for tracking the impact of genomics on population health.

Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ.

Genet Med. 2016 Dec;18(12):1312-1314. doi: 10.1038/gim.2016.63. Epub 2016 Jun 9.


Clinical utility of genetic and genomic services: context matters.

Dotson WD, Bowen MS, Kolor K, Khoury MJ.

Genet Med. 2016 Jul;18(7):672-4. doi: 10.1038/gim.2015.153. Epub 2015 Dec 10. No abstract available.


Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC).

Green RF, Dotson WD, Bowen S, Kolor K, Khoury MJ.

Healthcare (Basel). 2015;3(3):830-7. Epub 2015 Sep 15.


Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.

Parkman AA, Foland J, Anderson B, Duquette D, Sobotka H, Lynn M, Nottingham S, Dotson WD, Kolor K, Cox SL.

J Genet Couns. 2015 Jun;24(3):512-21. doi: 10.1007/s10897-014-9771-y. Epub 2014 Sep 23.


Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ.

Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9.


Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ.

Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19. Review.


A DNA sequence element that advances replication origin activation time in Saccharomyces cerevisiae.

Pohl TJ, Kolor K, Fangman WL, Brewer BJ, Raghuraman MK.

G3 (Bethesda). 2013 Nov 6;3(11):1955-63. doi: 10.1534/g3.113.008250.


Public health action in genomics is now needed beyond newborn screening.

Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ.

Public Health Genomics. 2012;15(6):327-34. doi: 10.1159/000341889. Epub 2012 Sep 11. Review.


Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice.

Kolor K, Duquette D, Zlot A, Foland J, Anderson B, Giles R, Wrathall J, Khoury MJ.

Genet Med. 2012 Oct;14(10):860-7. doi: 10.1038/gim.2012.67. Epub 2012 Jul 19.


Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.

Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ.

Am J Prev Med. 2011 Jan;40(1):61-6. doi: 10.1016/j.amepre.2010.09.027.


Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008.

Kolor K, Liu T, St Pierre J, Khoury MJ.

Genet Med. 2009 Aug;11(8):595. doi: 10.1097/GIM.0b013e3181b1cc2c. No abstract available.


Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.

Bobo JK, Kenneson A, Kolor K, Brown MA.

Pediatrics. 2009 Mar;123(3):e471-5. doi: 10.1542/peds.2008-2643.


Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.

Palomaki GE, Bradley LA, Douglas MP, Kolor K, Dotson WD.

Genet Med. 2009 Jan;11(1):21-34. doi: 10.1097/GIM.0b013e31818efd77. Review.


A decade of public health genomics in the United States: centers for disease control and prevention 1997-2007.

Khoury MJ, Bowen S, Bradley LA, Coates R, Dowling NF, Gwinn M, Kolor K, Moore CA, St Pierre J, Valdez R, Yoon PW.

Public Health Genomics. 2009;12(1):20-9. doi: 10.1159/000153427. Epub 2008 Sep 3. Review.


Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.

Coates RJ, Kolor K, Stewart SL, Richardson LC.

Clin Cancer Res. 2008 Nov 15;14(22):7575-6; author reply 7577-9. doi: 10.1158/1078-0432.CCR-08-2296. Epub 2008 Oct 23. No abstract available.


Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: an analysis of multiple cause mortality data.

Kenneson A, Kolor K, Yang Q, Olney RS, Rasmussen SA, Friedman JM.

Am J Med Genet A. 2006 Nov 1;140(21):2289-97.


On the role of the P-site in leftward ribosome frameshifting at a hungry codon.

Kolor K, Lindsley D, Gallant JA.

J Mol Biol. 1993 Mar 5;230(1):1-5.


The topography of chromosome replication in yeast.

Brewer BJ, Diller JD, Friedman KL, Kolor KM, Raghuraman MK, Fangman WL.

Cold Spring Harb Symp Quant Biol. 1993;58:425-34. No abstract available.


Supplemental Content

Support Center